Marc Claret receives a “Proof of Concept” grant from the European Research Council
Marc Claret, the head of IDIBAPS’ Neuronal Control of Metabolism Neucome research group, has received a “Proof of Concept Grant” from the European Re1
Marc Claret, the head of IDIBAPS’ Neuronal Control of Metabolism Neucome research group, has received a “Proof of Concept Grant” from the European Re1
Endowed with €12 million, the project is coordinated by Prof. Josep M. Llovet, the head of the IDIBAPS group Translational Research in Hepatic Oncolo1
The IDIBAPS Board of Trustees has approved the creation of a new research group. The decision results from a scientific evaluation by the ad hoc comm1
The clinical trial RATIO37 has shown in 11,500 low-risk pregnant women that adding a Doppler study of fetal circulation in the last ultrasound can re1
IDIBAPS is looking for outstanding researchers in Translational Medicine to prepare a joint application to the new call by the ICREA
A study coordinated by researchers at the Hospital Clínic-IDIBAPS reveals that characterizing the type of neovascular lesion in the eye of patients w1
His research career focuses on hepatic vascular pathophysiology, acute and chronic liver diseases, as well as, the aging process.
Using mouse models and human samples, a team from Clínic-IDIBAPS has detected that low expression of the ZEB1 gene increases the size of atherosclero1
The model was created by injecting tumour cells from a patient into a mouse. This makes it possible to imitate the leukaemia’s transformation into a1
The largest meta-analysis to date defines the specific risk that a child of a person with a mental disorder will develop a mental health problem. The1